{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:30Z","timestamp":1792643970825,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.htct.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T08:36:34Z","timestamp":1594024594000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-3780","authenticated-orcid":false,"given":"Rodolfo D.","family":"Can\u00e7ado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderson da Silva","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Freire","family":"Sandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arrais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse Lopes de Castro","family":"Lobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra F\u00e1tima Menosi","family":"Gualandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Teresinha Olalla","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.htct.2020.06.006_bib0005","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2020.06.006_bib0010","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-148-8-200804150-00003","article-title":"Narrative review: paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia","volume":"148","author":"Brodsky","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.htct.2020.06.006_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0029-1196307","article-title":"Paroxysmale haemoglobinurie","volume":"8","author":"Strubing","year":"1882","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.htct.2020.06.006_bib0020","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/BF01846778","article-title":"Eine neue form intermittierender haemoglobinurie (Haemoglobinuria paroxysmalis nocturia)","volume":"7","author":"Enneking","year":"1928","journal-title":"Klin Wochenschr"},{"issue":"23","key":"10.1016\/j.htct.2020.06.006_bib0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM193712022172307","article-title":"Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria. A study of the mechanism of hemolysisin relation to acid base equilibrium","volume":"217","author":"Ham","year":"1937","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.htct.2020.06.006_bib0030","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.htct.2020.06.006_bib0035","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2020.06.006_bib0040","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1182\/blood.V108.11.985.985","article-title":"The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire","volume":"108","author":"Hill","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.htct.2020.06.006_bib0045","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.4049\/jimmunol.144.9.3478","article-title":"The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9","volume":"144","author":"Rollins","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.htct.2020.06.006_bib0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.iy.07.040189.000343","article-title":"Decay-accelerating factor: biochemistry, molecular biology, and function","volume":"7","author":"Lublin","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"17","key":"10.1016\/j.htct.2020.06.006_bib0055","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2008-11-189944","article-title":"Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab","volume":"113","author":"Risitano","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.htct.2020.06.006_bib0060","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1182\/blood.V87.12.5332.bloodjournal87125332","article-title":"The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria","volume":"87","author":"Hall","year":"1996","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.htct.2020.06.006_bib0065","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1182\/blood-2009-03-195966","article-title":"How I treat paroxysmal nocturnal hemoglobinuria","volume":"113","author":"Brodsky","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.htct.2020.06.006_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/ajcp\/114.3.459","article-title":"Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin","volume":"114","author":"Brodsky","year":"2000","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.htct.2020.06.006_bib0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","article-title":"Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry","volume":"78","author":"Borowitz","year":"2010","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.htct.2020.06.006_bib0080","first-page":"257","article-title":"Flow cytometric analysis of GPI-deficient cells for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)","volume":"27","author":"Nebe","year":"2003","journal-title":"J Lab Med"},{"issue":"8","key":"10.1016\/j.htct.2020.06.006_bib0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00277-011-1177-4","article-title":"Paroxysmal nocturnal hemo\u00ad globinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes","volume":"90","author":"H\u00f6chsmann","year":"2011","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.htct.2020.06.006_bib0090","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0095","article-title":"Paroxysmal nocturnal hemoglobinuria (PNH) guideline: recommendations from the society for diagnosis and therapy of haematological and oncological diseases","author":"Schubert","year":"2012","journal-title":"Onkopedia"},{"issue":"1","key":"10.1016\/j.htct.2020.06.006_bib0100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0609.2011.01615.x","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia","volume":"87","author":"Pu","year":"2011","journal-title":"Eur J Haematol"},{"issue":"25","key":"10.1016\/j.htct.2020.06.006_bib0105","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.htct.2020.06.006_bib0110","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.htct.2020.06.006_bib0115","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.htct.2020.06.006_bib0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2006.01873.x","article-title":"A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression","volume":"4","author":"Maroney","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.htct.2020.06.006_bib0125","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.htct.2020.06.006_bib0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.thromres.2012.04.001","article-title":"Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation","volume":"130","author":"Weitz","year":"2012","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.htct.2020.06.006_bib0135","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ajh.21506","article-title":"Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria","volume":"84","author":"Emadi","year":"2009","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.htct.2020.06.006_bib0140","first-page":"19","article-title":"Pesg PNH diagnosis, follow-up and treatment guidelines","volume":"6","author":"Sahin","year":"2016","journal-title":"Am J Blood Res"},{"issue":"8","key":"10.1016\/j.htct.2020.06.006_bib0145","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ajh.21757","article-title":"Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria","volume":"85","author":"Hillmen","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.htct.2020.06.006_bib0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","article-title":"Effect of eculizumab on hemolysis-associated nitric oxide depletion, dyspnea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal hemoglobinuria","volume":"149","author":"Hill","year":"2010","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.htct.2020.06.006_bib0155","article-title":"Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal hemoglobinuria","volume":"146","author":"Villegas","year":"2016","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"10.1016\/j.htct.2020.06.006_bib0160","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3324\/haematol.2012.062828","article-title":"Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria","volume":"97","author":"Peffault de Latour","year":"2012","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.htct.2020.06.006_bib0165","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3324\/haematol.2010.023176","article-title":"Stem cell transplantation for paroxysmal nocturnal hemoglobinuria","volume":"95","author":"Brodsky","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.htct.2020.06.006_bib0170","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0301-472X(01)00632-4","article-title":"Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria","volume":"29","author":"Suenaga","year":"2001","journal-title":"Exp Hematol"},{"issue":"22","key":"10.1016\/j.htct.2020.06.006_bib0175","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","article-title":"HLAhaploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease","volume":"120","author":"Bola\u00f1os-Meade","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0180","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0185","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","article-title":"Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH)","volume":"102","author":"Hall","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.htct.2020.06.006_bib0190","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.htct.2020.06.006_bib0195","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.htct.2020.06.006_bib0200","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3324\/haematol.2009.007229","article-title":"Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization","volume":"95","author":"Hill","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.htct.2020.06.006_bib0205","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12347","article-title":"Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria","volume":"162","author":"Hillmen","year":"2013","journal-title":"Br J Haematol"},{"issue":"25","key":"10.1016\/j.htct.2020.06.006_bib0210","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0215","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/imj.13523","article-title":"Clinical benefit of eculizumab in patients with no transfusion history in the International Paroxysmal Nocturnal. Haemoglobinuria Registry","volume":"47","author":"Almeida","year":"2017","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.htct.2020.06.006_bib0220","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2013.090001","article-title":"Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria","volume":"99","author":"Rondelli","year":"2014","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.htct.2020.06.006_bib0225","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2020.06.006_bib0230","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.htct.2020.06.006_bib0235","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1182\/blood-2011-12-398792","article-title":"The complement receptor 2\/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment","volume":"119","author":"Risitano","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0240","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood.V122.21.2466.2466","article-title":"Red cell Complement loading in PNH patients on eculizumab is associated with a C3 polymorphism which influences C3 function, predicts for increased extravascular hemolysis and provides a rationale for C3 inhibition","volume":"122","author":"Kaudlay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.htct.2020.06.006_bib0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2010.08099.x","article-title":"The management of pregnancy in paroxysmal nocturnal hemoglobinuria on long term eculizumab","volume":"149","author":"Kelly","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2020.06.006_bib0250","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.ogx.0000234794.27485.59","article-title":"Clinical management of paroxysmal nocturnal hemoglobinuria in pregnancy: a case report and updated review","volume":"61","author":"Fieni","year":"2006","journal-title":"Obstet Gynecol Surv"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137920300791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:33:46Z","timestamp":1762868026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137920300791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2531137920300791"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2020.06.006","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Editora Ltda. on behalf of Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular.","name":"copyright","label":"Copyright"}]}}